HK1025732A1 - Wound healing and treatment of fibrosis - Google Patents

Wound healing and treatment of fibrosis

Info

Publication number
HK1025732A1
HK1025732A1 HK00101571A HK00101571A HK1025732A1 HK 1025732 A1 HK1025732 A1 HK 1025732A1 HK 00101571 A HK00101571 A HK 00101571A HK 00101571 A HK00101571 A HK 00101571A HK 1025732 A1 HK1025732 A1 HK 1025732A1
Authority
HK
Hong Kong
Prior art keywords
fibrosis
treatment
wound healing
compound
gelsolin
Prior art date
Application number
HK00101571A
Other languages
English (en)
Inventor
Mark William James Ferguson
Sharon O'kane
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625148.3A external-priority patent/GB9625148D0/en
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of HK1025732A1 publication Critical patent/HK1025732A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK00101571A 1996-12-04 2000-03-15 Wound healing and treatment of fibrosis HK1025732A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625148.3A GB9625148D0 (en) 1996-12-04 1996-12-04 Wound healing
US3211596P 1996-12-05 1996-12-05
PCT/GB1997/003243 WO1998024465A1 (en) 1996-12-04 1997-12-04 Wound healing and treatment of fibrosis

Publications (1)

Publication Number Publication Date
HK1025732A1 true HK1025732A1 (en) 2000-11-24

Family

ID=26310539

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101571A HK1025732A1 (en) 1996-12-04 2000-03-15 Wound healing and treatment of fibrosis

Country Status (12)

Country Link
US (2) US20020103112A1 (xx)
EP (1) EP0941108B1 (xx)
JP (1) JP2001505219A (xx)
AT (1) ATE226084T1 (xx)
AU (1) AU744750B2 (xx)
CA (1) CA2274002A1 (xx)
DE (1) DE69716460T2 (xx)
DK (1) DK0941108T3 (xx)
ES (1) ES2183220T3 (xx)
HK (1) HK1025732A1 (xx)
PT (1) PT941108E (xx)
WO (1) WO1998024465A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002522462A (ja) * 1998-08-13 2002-07-23 ハダシット・メディカル・リサーチ・サービシイズ・アンド・ディベロプメント・カンパニー・リミテッド 組織外傷に関連した病原プロセスの阻害
EP1270044A3 (en) * 2001-06-18 2003-03-12 Pfizer Limited Wound healing biomarkers
US7301020B2 (en) * 2003-06-19 2007-11-27 Wisconsin Alumni Research Foundation Macrolide analogs and methods for identifying same
US9408891B2 (en) * 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
EP1694342B1 (en) * 2003-11-12 2020-11-04 Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
KR101300929B1 (ko) * 2004-05-12 2013-08-27 더 브리검 앤드 우먼즈 하스피털, 인크. 감염 치료를 위한 겔솔린의 용도
AU2006308431B2 (en) * 2005-10-25 2011-11-10 Adelaide Research & Innovation Pty Ltd Methods and compositions for modulating wound repair
JP5153639B2 (ja) * 2005-10-25 2013-02-27 ウィミンズ アンド チルドレンズ ヘルス リサーチ インスティテュート 創傷修復を調節するための方法及び組成物
HUE035884T2 (en) 2006-03-15 2018-05-28 Brigham & Womens Hospital Inc The use of gelsolin for the diagnosis and treatment of inflammatory diseases
JP2009530613A (ja) * 2006-03-15 2009-08-27 ザ・ブリガム・アンド・ウイメンズ・ホスピタル・インコーポレイテッド 多発性硬化症を治療するため、および神経疾患を診断するための、ゲルゾリンの使用
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
PL2250280T3 (pl) * 2008-01-25 2015-06-30 Massachusetts Gen Hospital Terapeutyczne zastosowania gelsoliny w niewydolności nerek
GB201003652D0 (en) * 2010-03-05 2010-04-21 Univ Cardiff Molecular target for healing or treating wounds
EP3263121B1 (en) * 2010-12-21 2019-02-27 Leidos, Inc. Methods and compositions for wound treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
DE3889479T2 (de) 1987-02-27 1994-12-22 Eastman Kodak Co Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung.
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
WO1991015770A1 (en) 1990-04-11 1991-10-17 The General Hospital Corporation Therapeutic uses of actin-binding compounds
AU8647991A (en) 1991-08-26 1993-03-16 State of Oregon Acting by and Through The State of Board of Higher Education on Behalf of The Oregon Health Sciences University, The Keratinocyte-derived conditioned medium as a source of growth factors
GB9206861D0 (en) 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines

Also Published As

Publication number Publication date
AU744750B2 (en) 2002-02-28
DE69716460T2 (de) 2003-06-26
US20020103112A1 (en) 2002-08-01
ES2183220T3 (es) 2003-03-16
PT941108E (pt) 2003-01-31
AU5401098A (en) 1998-06-29
JP2001505219A (ja) 2001-04-17
DK0941108T3 (da) 2002-11-18
CA2274002A1 (en) 1998-06-11
WO1998024465A1 (en) 1998-06-11
DE69716460D1 (de) 2002-11-21
EP0941108A1 (en) 1999-09-15
US20070087969A1 (en) 2007-04-19
US7566446B2 (en) 2009-07-28
EP0941108B1 (en) 2002-10-16
ATE226084T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
HK1025732A1 (en) Wound healing and treatment of fibrosis
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
AU2595697A (en) Compounds and compositions for delivering active agents
AU4859793A (en) Sulfated ligands for l-selectins and use of chlorates and or sulfatases for the treatment of inflammation
HK1017995A1 (en) Compounds and compositions for delivering active agents.
ZA949418B (en) Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
GR1003011B (el) Νεα συνθεση
AU5296593A (en) Concentrated mouthrinse for efficient delivery of antimicrobials
ZA933023B (en) The use of inhibitors of plasminogen activators for the treatment of inflammations and wounds.
EP0640647A3 (en) Ion-crosslinked glycosaminoglycan gels to increase soft tissue and for drug delivery.
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
ZA936692B (en) Physiologically active peptide composition
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
SG47158A1 (en) Improving the tolerability of pharmaceutically active b-amino acids
AU3733293A (en) Method and agents for promoting wound healing
AU5531798A (en) Pharmacologically active compounds and use
EP0959887A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USING THE SAME
AU1720097A (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
AU8393391A (en) Splint and bandage applicator
GB9205784D0 (en) Biologically and therapeutically active agents against hiv-1
GB9306974D0 (en) Biologically and therapeutically active agents against hiv-1
HUP9901162A3 (en) Compounds and compositions for delivering active agents
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.
GB9613322D0 (en) Biologically and therapeutically active agents against HIV-1

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111204